GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Upper GI Tract/Anorexia Nervosa and Bulimia Nervosa

Anorexia Nervosa and Bulimia Nervosa

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated April 1, 2025

Quick Answer

Anorexia Nervosa (AN) and Bulimia Nervosa (BN) are two of the most common eating disorders, both of which involve significant disturbances in eating behavior and an intense preoccupation with body weight, shape, and appearance. While they share some similarities, they are distinct disorders with unique clinical presentations, pathophysiology, and complications.


Anorexia Nervosa (AN) and Bulimia Nervosa (BN) are two of the most common eating disorders, both of which involve significant disturbances in eating behavior and an intense preoccupation with body weight, shape, and appearance. While they share some similarities, they are distinct disorders with unique clinical presentations, pathophysiology, and complications. Below is a detailed overview of both conditions:

---

## **Anorexia Nervosa (AN)**

### **Definition**:

Anorexia nervosa is a psychiatric disorder characterized by **self-imposed starvation**, an intense fear of gaining weight, and a distorted body image. Individuals with AN often have significantly low body weight and suffer from severe malnutrition.

### **Diagnostic Criteria (DSM-5)**:

1. **Restriction of energy intake** leading to significantly low body weight (less than minimally normal for age, sex, and health).

2. **Intense fear of gaining weight** or becoming fat, even when underweight.

3. **Disturbance in body image**, undue influence of body weight/shape on self-evaluation, or persistent lack of recognition of the seriousness of low body weight.

### **Types of Anorexia Nervosa**:

1. **Restricting Type**: Weight loss is achieved through strict dieting, fasting, or excessive exercise.

2. **Binge-Eating/Purging Type**: Regular episodes of binge eating followed by purging behaviors (e.g., self-induced vomiting or misuse of laxatives, diuretics, or enemas).

### **Pathophysiology**:

  • **Neuroendocrine Dysregulation**: Dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis, leading to hormonal imbalances such as reduced gonadotropins, thyroid hormones, and increased cortisol levels.
  • **Starvation Effects**: Chronic caloric restriction causes metabolic adaptations like bradycardia, hypothermia, and reduced basal metabolic rate.
  • **Psychological Factors**: Perfectionism, anxiety disorders, and obsessive-compulsive traits are common comorbidities.

### **Clinical Features**:

1. **Systemic Features**:

  • Severe weight loss, emaciation.
  • Hypothermia, bradycardia, hypotension.
  • Amenorrhea (absence of menstruation) in females due to hormonal imbalances.
  • Fatigue, brittle nails, thinning hair, and lanugo (fine body hair).

2. **Gastrointestinal Symptoms**:

  • **Gastroparesis**: Delayed gastric emptying leading to bloating, early satiety, nausea, and constipation.
  • **Abdominal pain**: Often caused by slowed gut motility.
  • **Refeeding Syndrome**: A dangerous condition when nutrition is reintroduced, causing electrolyte imbalances (e.g., hypophosphatemia), cardiac arrhythmias, and fluid shifts.

3. **Psychological Features**:

  • Distorted body image and intense fear of weight gain.

### **Complications**:

1. **Cardiovascular**: Bradycardia, hypotension, arrhythmias, and heart failure.

2. **Endocrine**: Hypothyroidism, osteoporosis (due to estrogen deficiency), and growth retardation in adolescents.

3. **Hematologic**: Anemia, leukopenia, and thrombocytopenia.

4. **Gastrointestinal**: Chronic constipation, gastric atrophy, and superior mesenteric artery syndrome.

5. **Neurological**: Cognitive impairment, peripheral neuropathy, and brain atrophy.

---

## **Bulimia Nervosa (BN)**

### **Definition**:

Bulimia nervosa is an eating disorder characterized by **recurrent episodes of binge eating** followed by **compensatory behaviors** such as self-induced vomiting, excessive exercise, or misuse of laxatives to prevent weight gain. Unlike anorexia nervosa, individuals with bulimia nervosa typically maintain a **normal or near-normal body weight**.

### **Diagnostic Criteria (DSM-5)**:

1. **Recurrent episodes of binge eating**, characterized by:

  • Eating an unusually large amount of food within a discrete period.
  • A sense of lack of control over eating during the episode.

2. **Recurrent compensatory behaviors** to prevent weight gain, such as vomiting, fasting, excessive exercise, or misuse of laxatives.

3. The binge eating and compensatory behaviors occur at least **once a week for three months**.

4. Self-evaluation is excessively influenced by body weight and shape.

### **Pathophysiology**:

  • **Neurochemical Imbalances**: Disruption in serotonin and dopamine pathways, which regulate appetite, mood, and reward systems.
  • **Behavioral Cycle**: Binge eating episodes are followed by feelings of guilt, shame, and compensatory behaviors, creating a vicious cycle.
  • **Gastrointestinal Effects**: Frequent vomiting leads to damage to the esophagus, teeth, and other parts of the GI tract.

### **Clinical Features**:

1. **Systemic Features**:

  • Normal or slightly overweight body weight.
  • Electrolyte disturbances (e.g., hypokalemia, hypochloremia, metabolic alkalosis due to vomiting).

2. **Gastrointestinal Symptoms**:

  • **Recurrent vomiting**: Causes dental enamel erosion, parotid gland swelling, and esophagitis.
  • **Constipation**: Often due to laxative abuse or dehydration.
  • **Abdominal pain**: Common after binge episodes.

3. **Psychological Features**:

  • Feelings of guilt, shame, and loss of control over eating.

### **Complications**:

1. **Gastrointestinal**:

  • Esophagitis, Barrett’s esophagus, and Mallory-Weiss tears.
  • Gastric rupture from severe binge eating.
  • Chronic constipation and rectal prolapse due to laxative abuse.

2. **Metabolic**:

  • Electrolyte imbalances (e.g., hypokalemia, hyponatremia) leading to arrhythmias.

3. **Dental**:

  • Enamel erosion, dental caries, and gum disease from stomach acid exposure due to repeated vomiting.

4. **Cardiovascular**:

  • Arrhythmias and cardiac arrest due to electrolyte imbalances.

---

## **Comparison Between Anorexia Nervosa and Bulimia Nervosa**

| **Feature** | **Anorexia Nervosa (AN)** | **Bulimia Nervosa (BN)** |

|-----------------------------|----------------------------------------------------------|--------------------------------------------------------|

| **Body Weight** | Significantly underweight (BMI < 17.5 kg/m²). | Normal or slightly overweight. |

| **Eating Behavior** | Restriction of caloric intake; may include purging. | Binge eating followed by compensatory behaviors. |

| **Body Image** | Distorted body image, intense fear of weight gain. | Preoccupation with body shape, but less distorted. |

| **Compensatory Behaviors** | May include purging, excessive exercise, or fasting. | Frequent purging (vomiting, laxatives, diuretics). |

| **Hormonal Effects** | Common (e.g., amenorrhea, osteoporosis). | Less common. |

| **Gastrointestinal Effects**| Severe (e.g., gastroparesis, superior mesenteric artery syndrome). | Vomiting-related damage (e.g., esophagitis, dental erosion). |

| **Prognosis** | Higher mortality due to medical complications. | Better prognosis but higher relapse rate. |

---

## **Management of Anorexia Nervosa and Bulimia Nervosa**

### **Multidisciplinary Approach**:

Effective treatment requires a team of healthcare professionals, including psychiatrists, psychologists, dietitians, and medical doctors.

### **Treatment Goals**:

1. **Nutritional Rehabilitation**:

  • For AN: Gradual refeeding to avoid **refeeding syndrome**.
  • For BN: Establishing regular and healthy eating habits.

2. **Psychotherapy**:

  • **Cognitive Behavioral Therapy (CBT)**: Gold standard for both disorders, addressing distorted thoughts about body image and eating behaviors.
  • **Family-Based Therapy (FBT)**: Particularly effective in adolescents with AN.

3. **Pharmacotherapy**:

  • **Anorexia Nervosa**: Medications have limited benefit, but antidepressants may help with comorbid anxiety or depression.
  • **Bulimia Nervosa**: **Fluoxetine (SSRI)** is FDA-approved for BN, reducing binge-purge episodes and improving mood.

4. **Monitoring for Complications**:

  • Electrolyte imbalances, cardiac arrhythmias, and other medical complications must be promptly addressed.
  • Hospitalization may be required in severe cases.

---

## **Prognosis**

1. **Anorexia Nervosa**:

  • Chronic and relapsing course.
  • Long-term mortality rate: 5–20%, primarily due to medical complications or suicide.
  • Early diagnosis and treatment improve outcomes.

2. **Bulimia Nervosa**:

  • Generally better prognosis compared to AN but has a higher relapse rate.
  • Long-term complications may occur if untreated.

---

## **Key Takeaways**:

  • **Anorexia Nervosa** involves extreme weight loss due to self-starvation and a distorted body image, often leading to life-threatening complications.
  • **Bulimia Nervosa** involves cycles of binge eating and compensatory behaviors (e.g., vomiting), with individuals maintaining a normal or slightly overweight body weight.
  • Both disorders significantly impact the gastrointestinal system and overall health, requiring a **multidisciplinary approach** for treatment.
  • Early diagnosis, nutritional rehabilitation, psychotherapy, and medical monitoring are essential for improving outcomes and preventing long-term complications.

Let me know if you need further clarification or have specific questions!

Related Q&A

Basal Crypt Dysplasia in Barrett's Esophagus: GUT | July 2026

Introduction: Barrett's esophagus (BE) is the principal precursor of esophageal adenocarcinoma. Early detection of neoplastic transformation is essential for preventing cancer progression. This review discusses basal crypt dysplasia (CD), an emerging histological entity that may...

High-Resolution Impedance Manometry after POEM: AJG | May 2026

Introduction: Assessing esophageal clearance after peroral endoscopic myotomy (POEM) is essential for evaluating treatment success in achalasia. Timed barium esophagram (TBE) is the current standard, but high-resolution impedance manometry (HRiM) may provide a radiation-free physiological...

Magnetic Sphincter Augmentation Provides Durable GERD Control : Ann Surg | Jun 2026

Introduction: Magnetic sphincter augmentation (MSA) has emerged as an effective surgical option for patients with gastroesophageal reflux disease (GERD) who continue to experience symptoms despite medical therapy. By augmenting lower esophageal sphincter function while preserving...

New Strategies Needed for Resistant H. pylori : Indian J Gastroenterol | Jun 2026

Introduction: Helicobacter pylori infection affects more than half of the global population and remains a major cause of peptic ulcer disease, gastric mucosal inflammation, and gastric cancer. Successful eradication is a cornerstone of gastrointestinal practice,...

Vonoprazan–Tetracycline Dual Therapy Simplifies H. pylori Rescue Treatment : Gastroenterology | June 2026

Introduction: Helicobacter pylori Infection eradication after prior treatment failure remains a major therapeutic challenge due to increasing antibiotic resistance, poor tolerability of multidrug regimens and declining adherence rates. Simplified rescue strategies with improved safety and...

H. pylori Eradication Reduces Cancer but Mortality Benefit Remains Fragile : Gastroenterology | June 2026

Introduction Helicobacter pylori Infection eradication is widely accepted as a key strategy for prevention of Gastric Cancer. Large meta-analyses have consistently shown reductions in gastric cancer incidence following eradication therapy, supporting global screening and treatment...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer